Basiliximab induction reduces the incidence of acute rejection in lung transplant patients

V. Mora Cuesta (Santander, Spain), D. Iturbe (Santander, Spain), L. González (Santander, Spain), T. Díaz (Santander, Spain), S. Fernández (Santander, Spain), A. Martínez (Santander, Spain), A. Sangrador (Santander, Spain), J. Gómez (Santander, Spain), A. Azueta (Santander, Spain), L. Sánchez (Santander, Spain), S. Naranjo (Santander, Spain), C. Álvarez (Santander, Spain), M. Carbajo (Santander, Spain), R. Mons (Santander, Spain), R. Alonso (Madrid, Spain), V. Pérez (Madrid, Spain), A. De Pablo (Madrid, Spain), J. Cifrián (Santander, Spain)

Source: International Congress 2018 – Moving lung transplantation forward
Session: Moving lung transplantation forward
Session type: Thematic Poster
Number: 2595
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Mora Cuesta (Santander, Spain), D. Iturbe (Santander, Spain), L. González (Santander, Spain), T. Díaz (Santander, Spain), S. Fernández (Santander, Spain), A. Martínez (Santander, Spain), A. Sangrador (Santander, Spain), J. Gómez (Santander, Spain), A. Azueta (Santander, Spain), L. Sánchez (Santander, Spain), S. Naranjo (Santander, Spain), C. Álvarez (Santander, Spain), M. Carbajo (Santander, Spain), R. Mons (Santander, Spain), R. Alonso (Madrid, Spain), V. Pérez (Madrid, Spain), A. De Pablo (Madrid, Spain), J. Cifrián (Santander, Spain). Basiliximab induction reduces the incidence of acute rejection in lung transplant patients. 2595

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Efficacy of tacrolimus rescue therapy in refractory acute rejection (AR) after lung transplantation
Source: Eur Respir J 2001; 18: Suppl. 33, 298s
Year: 2001

Rapamycin in patients with chronic lung rejection
Source: Eur Respir J 2005; 26: Suppl. 49, 635s
Year: 2005

Evaluation of lung mechanics and the progression of disease in acute allograft rejection after lung transplantation
Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation
Year: 2010

TNFα-308 polymorphism associates with acute lung allograft rejection
Source: Eur Respir J 2005; 26: Suppl. 49, 175s
Year: 2005

Mycophenolate mofetil reduces alveolar inflammation and acute rejection and improves overall outcome after lung transplantation
Source: Eur Respir J 2006; 28: Suppl. 50, 724s
Year: 2006

Pronounced neutrophil-rich inflammation in induced sputum of lung transplant recipients with chronic rejection
Source: Eur Respir J 2001; 18: Suppl. 33, 297s
Year: 2001

A model of chronic lung allograft rejection in the rat
Source: Eur Respir J 2010; 35: 1354-1363
Year: 2010



A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation
Source: Eur Respir J 2011; 37: 164-172
Year: 2011



Pathophysiology of the lung allograft: pathways of graft rejection
Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients
Year: 2005


Immunosuppressive therapy after human lung transplantation
Source: Eur Respir J 2004; 23: 159-171
Year: 2004



T-cell response against tuberculosis antigens is dependent on the level of immunosuppression in renal and lung transplant patients
Source: Eur Respir J 2006; 28: Suppl. 50, 344s
Year: 2006

CMV management in lung transplant recipients
Source: School Course 2012 - Lung Transplantation
Year: 2012


Effect of the type of end-stage lung disease on postoperative evolution of lung transplantation patients
Source: Annual Congress 2012 - Optimising outcomes after lung transplantation
Year: 2012


Electronic nose for detecting chronic lung allograft dysfunction in lung transplant recipients
Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward?
Year: 2021



Preemptive therapy for systemic and pulmonary human cytomegalovirus infection in lung transplant recipients
Source: Annual Congress 2009 - Lung transplantation: pre- and postoperative problems
Year: 2009


Immunosuppressive therapy after human lung transplantation
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=105
Year: 2003

Dichotomy in pulmonary graft-versus-host disease evident among allogeneic stem-cell transplant recipients undergoing lung transplantation
Source: Eur Respir J 2016; 48: 1807-1810
Year: 2016


II-17 upregulation in BAL-fluid during acute rejection after lung transplantation: a 3 months follow-up
Source: Eur Respir J 2004; 24: Suppl. 48, 180s
Year: 2004

Azithromycin treatment in patients with BOS after lung transplantation
Source: ISSN=ISSN 1810-6838, ISBN=, page=178
Year: 2005

Azithromycin (Azi) treatment for chronic allograft dysfunction after lung transplantation (LTx)
Source: Annual Congress 2003 - Bronchiolitis obliterans: diagnosis and treatment
Year: 2003